Neuropsychiatry

Latest News

Solarseven/AdobeStock
Phase 1 Clinical Trial Launched Examines Safety, Efficacy of Stem Cell Treatment for Parkinson Disease

March 10th 2025

A new trial is testing a first-of-its-kind stem cell therapy for Parkinson disease, using a patient’s own reprogrammed cells to restore lost dopamine function.

phase 1
Phase 1 Study Initiated: NBI-1140675 for Neurological and Neuropsychiatric Conditions

March 5th 2025

frontal lobe
Frontal Lobe Syndrome: Improving Patient Quality of Life

February 20th 2025

concussion
Biomarkers for Concussion: Current Insights and Future Directions

January 16th 2025

Alzheimer
FDA Accepts Biologics License Application for Lecanemab-irmb

January 14th 2025

Latest CME Events & Activities

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Southern Florida Psychiatry Conference

November 21-22, 2025

Register Now!

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

Optimizing Care for Patients With Tardive Dyskinesia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.